Skip to main content
Equibles

PICTON MAHONEY ASSET MANAGEMENT

Position in ZYME — Zymeworks Inc.

CIK 1539041 Toronto, A6
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$7,092,906
+$665,389 QoQ
Shares Held
271,343
+5.7% QoQ
Ownership
0.382%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#30
of 202 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PICTON MAHONEY ASSET MANAGEMENT holds $71,124,535 across 24 Biotechnology names. ZYME ranks #4 (10.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 APGE
Apogee Therapeutics, Inc.
 165,000 $21,900,450
2 QURE
uniQure N.V.
 181,215 $8,346,762
3 RYTM
Rhythm Pharmaceuticals, Inc.
 65,880 $7,314,656
4 ZYME
Zymeworks Inc.
This page 		271,343 $7,092,906
5 MIRM
Mirum Pharmaceuticals, Inc.
 47,679 $5,581,780
6 CAI
Caris Life Sciences, Inc.
 264,064 $4,705,620
7 CGON
CG Oncology, Inc.
 63,867 $4,537,750
8 ABVX
Abivax S.A.
 27,712 $3,692,901

All Filings in ZYME

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,092,906 271,343
2026-03-31 $6,427,517 256,690
2025-12-31 $6,445,531 244,798
2025-09-30 $3,523,979 206,322
2025-06-30 $2,605,405 207,602
2025-03-31 $2,477,625 208,029
2024-12-31 $3,024,170 206,569
2024-09-30 $3,070,432 244,656
2024-06-30 $2,082,890 244,758
2024-03-31 $2,991,656 284,378
2023-12-31 $3,708,253 356,906
2023-09-30 $2,274,906 358,818
2023-06-30 $3,025,416 350,164
2023-03-31 $2,870,380 317,520
2022-12-31 $2,035,771 259,004